BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34750021)

  • 1. Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors.
    Buza N
    Semin Diagn Pathol; 2022 Jan; 39(1):58-77. PubMed ID: 34750021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current WHO classification of the female genitals : Many new things, but also some old].
    Mayr D; Schmoeckel E; Höhn AK; Hiller GGR; Horn LC
    Pathologe; 2021 May; 42(3):259-269. PubMed ID: 33822250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in the pathological arena of gynecological cancers.
    McCluggage WG
    Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):107-114. PubMed ID: 34669206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas.
    Wang M; Hui P
    Arch Pathol Lab Med; 2021 Nov; 145(11):1367-1378. PubMed ID: 34673912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry in Gynecologic Pathology: An Example-Based Practical Update.
    Buza N; Hui P
    Arch Pathol Lab Med; 2017 Aug; 141(8):1052-1071. PubMed ID: 28745567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
    Zuna RE; Behrens A
    J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in the Classification of Gynecological Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book".
    Parkash V; Aisagbonhi O; Riddle N; Siddon A; Panse G; Fadare O
    Arch Pathol Lab Med; 2023 Oct; 147(10):1204-1216. PubMed ID: 36596270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesonephric-like Adenocarcinoma of the Female Genital Tract: From Morphologic Observations to a Well-characterized Carcinoma With Aggressive Clinical Behavior.
    McCluggage WG
    Adv Anat Pathol; 2022 Jul; 29(4):208-216. PubMed ID: 35384888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
    Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA3 Expression in Common Gynecologic Carcinomas: A Potential Pitfall.
    Terzic T; Mills AM; Zadeh S; Atkins KA; Hanley KZ
    Int J Gynecol Pathol; 2019 Sep; 38(5):485-492. PubMed ID: 30059453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG; Young RH
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
    Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
    Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders.
    Kaspar HG; Crum CP
    Arch Pathol Lab Med; 2015 Jan; 139(1):39-54. PubMed ID: 25549143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD10 expression in the female genital tract: does it have useful diagnostic applications?
    Oliva E
    Adv Anat Pathol; 2004 Nov; 11(6):310-5. PubMed ID: 15505532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical study of neuroendocrine cells in gynecologic tumors.
    Ueda G; Shimizu C; Saito J; Inoue Y; Tanaka Y; Inoue M; Tanizawa O
    Int J Gynaecol Obstet; 1989 Jun; 29(2):165-72. PubMed ID: 2568293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
    Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
    Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.